KK

Krupa Krutik Shah

Active Director Designated Partner DIN 10013469
DIN 10013469 First appointment Aug 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Krupa Krutik Shah

Data last updated:

Krupa Krutik Shah is a Designated Partner at Samuel Hahnemann Academy For Homeopathy Llp (since 2022). The company operates in Healthcare.

DIN 10013469
Primary Designation Designated Partner
Industry Healthcare
First Appointment 01 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Aug 20222022Active

Board colleagues of Krupa Krutik Shah

NameDINCompanyDesignation
Krutikkumar Hareshbhai Shah10013468Samuel Hahnemann Academy For Homeopathy LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Samuel Hahnemann Academy For Homeopathy Llp
Premium access

Shareholding and investment profile for Krupa Krutik Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krupa Krutik Shah

Krupa Krutik Shah currently holds 1 directorship: Samuel Hahnemann Academy For Homeopathy Llp (Designated Partner, since 01 Aug 2022).

Krupa Krutik Shah was first appointed on 01 Aug 2022 as Designated Partner at Samuel Hahnemann Academy For Homeopathy Llp.

The current boards of Krupa Krutik Shah's companies include Krutikkumar Hareshbhai Shah (Samuel Hahnemann Academy For Homeopathy Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available